Schedule 13G ownership disclosure

BIOMX INC

Common Stock, $0.0001 par value per share · CUSIP: 09090D103

Event date: 2025-02-27

Filing-level shares
2,494,110
Percent of class
9.99%
  • Cystic Fibrosis Foundation

    Shares: 2,494,110 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-032501
Form type
SCHEDULE 13G/A
Filer
BiomX Inc.
CIK
CIK 1739174
Filed
Mar 04, 2025
Reporting period
Feb 27, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub